Improved Chemosensitivity in Metastatic Castration‐Resistant Prostate Cancer: The Synergistic Effects of S‐Adenosylmethionine and Cabazitaxel

ABSTRACT Metastatic castration‐resistant prostate cancer (mCRPC) is the most aggressive kind of prostate cancer (PCa). Because the traditional taxane‐based therapy is ineffective, cabazitaxel (CBZ), a second‐generation, semisynthetic taxane, has been developed. Despite it demonstrating efficacy in p...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Roberta Arpino, Francesca Cadoni, Cristina Pagano, Laura Coppola, Vitale Del Vecchio, Aditya Nigam, Laura Mosca, Marina Porcelli
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2026-04-01
Sarja:	Cancer Medicine
Aiheet:	adjuvant chemoterapy apoptosis cabazitaxel metastatic castration‐resistant prostate cancer oxidative stress S‐adenosyl‐L‐methionine
Linkit:	https://doi.org/10.1002/cam4.71784
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!